Phlebology training curriculum. A consensus document of the International Union Of Phlebology (UIP)-2010

International Angiology

Volumn 29, Issue 6, 2010, Pages 533-559

  Parsi, K ^a   Zimmet, S ^b   Allegra, C ^c   Bergan, J ^d   Gasparis, A P ^e   Labropoulos, N ^e   Lee, B B ^f   Malouf, G M ^g   Partsch, H ^h   Rabe, E ⁱ   Ramelet, A A ^j   Schadeck, M ^k   Vin, F ^l  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Zimmet Vein and Dermatology Clinic   (United States)

^c MOLINETTE HOSPITAL   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WESTMEAD HOSPITAL   (Australia)

^h Universitatsklinik fur Dermatologie   (Austria)

ⁱ UNIVERSITY OF BONN   (Germany)

^j UNIVERSITY OF BERN   (Switzerland)

^k HÔPITAL TENON   (France)

^l AMERICAN HOSPITAL OF PARIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CURRICULUM; INTERNATIONAL COOPERATION; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; PHLEBOLOGY; PUBLICATION; REVIEW;

ANATOMY; CLINICAL COMPETENCE; CURRICULUM; DIAGNOSTIC IMAGING; EDUCATION, MEDICAL, GRADUATE; EDUCATION, MEDICAL, UNDERGRADUATE; ENDOVASCULAR PROCEDURES; HUMANS; PEDIATRICS; PHARMACOLOGY; SOCIETIES, MEDICAL; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES; VEINS;

EID: 79952302679     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Caggiati A, Bergan JJ, Gloviczki P, Jantet G, Wendell-Smith CP, Partsch H. Nomenclature of the veins of the lower limbs: an International Interdisciplinary Consensus Statement. J Vasc Surg. 2002;36:416-22. (Pubitemid 35014985)
2. Eklof B, Perrin M, Delis K, Rutherford R, Gloviczki P. Updated terminology of chronic venous disorders: the VEIN-TERM Transatlantic Interdisciplinary Consensus Document. J Vasc Surg 2009;49:498-501.
3. Kachlik D, Pechacek V, Baca V, Musil V. The superficial venous system of the lower extremity: new nomenclature. Phlebology 2010;25:113-23.
4. Mozes G, Gloviczki P. New discoveries in anatomy and new terminology of leg veins: clinical implications. Vasc Endovascular Surg 2004;38:367-74. (Pubitemid 39079943)
5. Partsch H, Clark M, Bassez S, Benigni JP, Becker F, Blazek V et al. Measurement of Lower Leg Compression in vivo: Recommendations for the Performance of Measurements of Interface Pressure and Stiffness: Consensus Statement. Dermatol Surg 2006;32: 224-32.
6. Wollmann JC. Sclerosant foams: stabilities, physical properties and rheological behavior. Phlebologie 2010;39:208-17.
7. Gañán-Calvo AM, Fernández JM, Marquez Oliver A, Marquez M. Coarsening of monodisperse wet microfoams. Appl Phys Lett 2004;84:4989-91.
8. Sun QC, Tan LH, Wang GQ. Liquid foam drainage: an overview. Int J Mod Phys B 2008;22:2333-54.
9. Rao J, Goldman MP. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg 2005;31:19-22.
10. le Maire M, Champeil P, Moller JV. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim Biophys Acta 2000;23:86-111.
11. Lurie F. Venous haemodynamics: what we know and don't know. Phlebology 2009;24:3-7.
12. Arellano AR, Bezemer ID, Tong CH, Catanese JJ, Devlin JJ, Reitsma PH et al. Gene variants associated with venous thrombosis: confirmation in the MEGA Study. J Thromb Haemost 2010;8:1132-4.
13. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong CH, Rowland CM et al. Gene Variants Associated with Deep Vein Thrombosis. JAMA 2008;299:1306-14. (Pubitemid 351439076)
14. Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 2010;25:224-35.
15. Al-Adnani M, Williams S, Rampling D, Ashworth M, Malone M, Sebire NJ. Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system. J Clin Pathol 2006;59:1278-82. (Pubitemid 46048332)
16. Ariëns RA. FXIII and fibrin clot structure. 53rd Annual GTH Meeting (Gesellschaft für Thrombose und Hämostaseforchung) Society of Thrombosis and Haemostasis Research; Vienna, Austria; 2009. p. 49.
17. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002;100:743-54. (Pubitemid 34832596)
18. Parsi K. Dermatological manifestations of venous disease. Part II: Reticulate Eruptions. Aust NZ J Phleb 2008;11:11-46.
19. Makris M, van Veen JJ, Maclean R. Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J Thromb Thrombolysis 2010 29:171-81.
20. Squizzato A, Dentali F, Ageno W. Treatment options for deep vein thrombosis. Expert Opin Pharmacother 2010;11:1069-75.
21. Chan V, Monagle P, Massicotte P, Chan A. Novel paediatric anticoagulants: a review of the current literature. Blood Coagul Fibrinolysis 2010;21:144-51.
22. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2005;3:CD003229.
23. Ramelet AA, Boisseau MR, Allegra C, Nicolaides A, Jaeger K, Carpentier P et al. Veno-active drugs in the management of chronic venous disease. An International Consensus Statement: Current Medical Position, Prospective Views and Final Resolution. Clin Hemorheol Microcirc 2005;33:309-19. (Pubitemid 41750556)
24. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive Therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg 2005;30:198-208. (Pubitemid 40932020)
25. Milio G, Mina C, Cospite V, Almasio PL, Novo S. Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs. J Vasc Surg 2005;42:304-8. (Pubitemid 41139238)
26. Jull AB, Waters J, Arroll B. Pentoxifylline for treating venous leg ulcers. Cochrane Database Syst Rev 2007;18:CD001733.
27. Parsi K. Dermatological manifestations of venous disease. Part I. Aust NZ J Phleb 2007;10:11-9.
28. Beebe-Dimmer JL, Pfeifer J, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. AEP 2005;15:175-84. (Pubitemid 40269465)
29. Carpentier PH, Maricq HR, Biro C, Poncot-Makinen CO, Franco A. Prevalence, risk factors and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg 2004;40:650-59. (Pubitemid 39328084)
30. Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicenter cross-sectional study in 40095 patients. Phlebology 2003;18:110-21.
31. Rabe E, Pannier-Fischer F, Bromen K, Schuld K, Poncar C, Wittenhorst M et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie Epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003;32:1-14.
32. Beebe HG, Bergan JJ, Bergqvist D, Eklof B, Eriksson I, Goldman MP et al. Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Eur J Vasc Endovasc Surg 1996;12:487-92. (Pubitemid 27032797)
33. Porter JM, Moneta GL. International Consensus Committee on chronic venous disease. Reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45.
34. Allegra C, Antignani PL, Bergan JJ, Carpentier PH, Coleridge-Smith P, Cornu-Thénard A et al. The "C" of CEAP: Suggested definitions and refinements: an international union of phlebology conference of experts. J Vasc Surg 2003;37:129-31.
35. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL et al. Revision of the CEAP Classification for Chronic Venous Disorders: Consensus Statement. J Vasc Surg 2004;40:1248-52. (Pubitemid 40037299)
36. Uhl JF, Comu-Thénard A, Carpentier PH, Schadek M, Parpex P, Chleir F. Reproducibility of the "C" Classes of the CEAP Classification. Phlebology 2001;1:39-48.
37. Rutherford RB, Padberg FT, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12. (Pubitemid 30418499)
38. Cavezzi A, Labropoulos N, Partsch H, Ricci S, Caggiati A, Myers K et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs-UIP Consensus Document. Part II. Anatomy. Eur J Vasc Endovasc Surg 2006;31:288-99. (Pubitemid 43263513)
39. Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs-UIP Consensus Document. Part I. Basic Principles. Eur J Vasc Endovasc Surg 2006;31:83-92. (Pubitemid 43024989)
40. Labropoulos N, Leon LR. Duplex evaluation of venous insufficiency. Semin Vasc Surg 2005;18:5-9.
41. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003;25:1-5. (Pubitemid 36527593)
42. Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 2010;29:489-96.
43. Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolism-trivial or not so trivial? Semin Thromb Hemost 2009;35:597-604.
44. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective Cohort Study. Lancet 2003;362:523-6. (Pubitemid 36976716)
45. Cohn D, Vansenne F, de Borgie C, Middeldorp S. Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev 2009;21:CD007069.
46. Coppens M, Reijnders JH, Middeldorp S, Doggen CJ, Rosendaal FR. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 2008;6:1474-7.
47. Labropoulos N, Spentzouris G, Gasparis AP, Meissner M. Impact and clinical significance of recurrent venous thromboembolism. Br J Surg 2010;97:989-99.
48. Lijfering WM, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR et al. A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood Coagul Fibrinolysis 2009;114:2031-6.
49. Djulbegovic B. Management of venous thromboembolism in cancer: a brief review of risk-benefit approaches and Guidelines' recommendations. J Support Oncol 2010;8:84-91.
50. Franchini M, Montagnana M, Favaloro EJ, Lippi G. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost 2009;35:644-53.
51. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007;139:289-96. (Pubitemid 47493087)
52. Middeldorp S. Epidemiology of hormone-related venous thromboembolism. Thromb Res 2009;123:65-9.
53. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA Study. J Thromb Haemost 2008;6:632-7. (Pubitemid 351404930)
54. Kuipers S, Schreijer AJ, Cannegieter SC, Büller HR, Rosendaal FR, Middeldorp S. Travel and venous thrombosis: a systematic review. J Intern Med 2007;262:615-34. (Pubitemid 350135194)
55. Schobersberger W, Schobersberger B, Partsch H. Travel-related thromboembolism: mechanisms and avoidance expert. Rev Cardiovasc Ther 2009;7:1559-67.
56. Schreijer AJ, Hoylaerts MF, Meijers JC, Lijnen HR, Middeldorp S, Büller HR et al. Explanations for coagulation activation after air travel. J Thromb Haemost 2010;8:971-8.
57. Rosendaal FR, van Hylckama Vlieg A, Doggen CJ. Venous thrombosis in the elderly. J Thromb Haemost 2007;5 310-7.
58. Neglén P, Thrasher TL, Raju S. Venous outflow obstruction: an underestimated contributor to chronic venous disease. J Vasc Surg 2003;38:879-85. (Pubitemid 37409616)
59. Dentali F, Ageno W. Cerebral vein thrombosis. Intern Emerg Med 2010;5:27-32.
60. Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R et al. International Consensus Statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:296-06.
61. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta M. Antiphospholipid Syndrome. Lancet 2010;376:1498-509.
62. Frances C. Dermatological manifestations of Hughes' Antiphospholipid Antibody Syndrome. Lupus 2010;19:1071-7.
63. Favaloro EJ, Wong RC. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian Antiphospholipid Antibody Survey. Pathology 2009;41:666-75.
64. Devreese K, Peerlinck K, Hoylaerts MF. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 2010;115:870-8.
65. Cervera R. Catastrophic Antiphospholipid Syndrome (CAPS): update from the 'CAPS Registry. Lupus 2010;19:412-8.
66. Pierangeli S, Erkan D. Antiphospholipid Syndrome Treatment beyond anticoagulation: are we there yet? Lupus 2010;19:475-85.
67. Schadek M. The venous valve and primary chronic venous disease. Medicographia 2008;30:106-11.
68. Lee BB, Bergan JJ, Gloviczki P, Laredo J, Loose DA, Mattassi R et al. Diagnosis and treatment of venous malformations: Consensus Document of the International Union of Phlebology (IUP)-2009. Int Angiol 2009;28:434-51.
69. Lee BB, Kim YW, Seo JM, Hwang JH, Do YS, Kim DI et al. Current concepts in lymphatic malformation (LM). J Vasc Endovasc Surg 2005;39:67-81.
70. Lee BB. Chapter 4. Lymphatic malformation. In: Tredbar, Morgan, Lee, Simonian, Blondeau, editors. Lymphedema-diagnosis and treatment: London: Springer-Verlag Limited; 2008. p. 31-42.
71. Lee BB, Villavicencio J. Primary lymphedema and lymphatic malformation: are they the two sides of the same coin? Eur J Vasc Endovasc Surg 2010;39:646-53.
72. Lee BB, Laredo J, Seo JM, Neville R. Chapter 29. Treatment of lymphatic malformations. In: Mattassi, Loose, Vaghi, editors. Hemangiomas and vascular malformations. Milan, Italy: Springer-Verlag Italia; 2009. p. 231-50.
73. Lee BB, Lardeo J, Neville R. Arterio-venous malformation: how much do we know? Phlebology 2009;24:193-200.
74. Lee BB, Villavicencio L. General considerations. Congenital vascular malformations. Section 9. Arteriovenous anomalies. In: Cronenwett J, Johnston K, editors. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA,: Saunders Elsevier; 2010. p. 1046-64.
75. Lee BB, Laredo J, Deaton DH, Neville RF. Arteriovenous malformations: evaluation and treatment. In: Gloviczki, editor. Handbook of venous disorders: Guidelines of the American Venous Forum. 3rd ed. London: Hodder Arnold Limited; 2009. p. 583-93.
76. Antignani PL, Schacther I, Allegra C. Skin necrosis during oral anticoagulant long-term treatment: an atypical side. Int Angiol 2009;28:82-3.
77. Parsi K, Younger I, Gallo J. Warfarin-induced skin necrosis associated with acquired protein C deficiency. Australas J Dermatol 2003;44:57-61. (Pubitemid 36246425)
78. Lee BB, Laredo J, Neville R. Embryological background of truncular venous malformation in the extracranial venous pathways as the cause of chronic cerebrospinal venous insufficiency. Int Angiol 2010;29:95-108.
79. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392-9.
80. Bianco-Molina A, Monreal M. Venous thromboembolism in women taking hormonal contraceptives. Expert Rev Cardiovasc Ther 2010;8:211-5.
81. Canonico M, Scarabin PY. Hormone therapy and risk of venous thromboembolism among postmenopausal women. Climacteric 2009;12:76-80.
82. Aydinli M, Bayraktar Y. Budd-Chiari Syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 2007;13:2693-6.
83. Lee BB. Chapter 6. Surgical management of lymphedema. In: Tredbar, Morgan, Lee, Simonian, Blondeau, editors. Lymphedema - Diagnosis and treatment. London: Springer-Verlag Limited; 2008. p. 55-63.
84. Lee BB, Andrade M, Bergan JJ, Boccardo F, Campisi C, Damstra R et al. Diagnosis and treatment of primary lymphedema - Consensus document of the international union of phlebology (IUP)-2009. Int Angiol 2010;29:454-70.
85. Lee BB, Morgan C. Chapter 3: classification and staging of lymphedema. In: Tredbar, Morgan, Lee, Simonian, Blondeau, editors. Lymphedema - Diagnosis and treatment. London: Springer-Verlag Limited; 2008. p. 21-30.
86. McMullin GM, Coleridge-Smith P. An evaluation of Doppler ultrasound and photoplethysmography in the investigation of venous insufficiency. Aust N Z J Surg 1992;62:270-5.
87. Abu-Own A, Coleridge-Smith P. Hand-held Doppler as a screening test in primary varicose veins. Br J Surg 1998;85:424.
88. Kim J, Richards S, Kent P. Clinical examination of varicose veins A validation study. Ann R Coll Surg Engl 2000;82:171-5. (Pubitemid 30255884)
89. Darke S, Vetrivel S, Foy D, Smith S, Baker S. A comparison of Duplex scanning and continuous wave Doppler in the assessment of primary and uncomplicated varicose veins. Eur J Vasc Endovasc Surg 1997;14:457-61.
90. Katz D, Loud AP, Bruce D, Gittleman AM, Mueller R, Klippenstein DL et al. Combined CT venography and pulmonary angiography: a comprehensive review. Radiographics 2002;22:20-4.
91. Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010;48:579-98.
92. Lippi G, Cervellin G, Franchini M, Favaloro EJ. Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future. J Thromb Thrombolysis 2010;30:459-71.
93. Wichers IM, Tanck MW, Meijers JC, Lisman T, Reitsma PH, Rosendaal FR et al. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Thromb Haemost 2009;101:465-70.
94. Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2010;36:458-67.
95. Baglin T, Gray E, Greaves M, Hunt B, Keeling D, Machin S et al. Clinical Guidelines for testing for heritable thrombophilia. Br J Haematol 2010;149:209-20.
96. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009;35:695-710.
97. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood Coagul Fibrinolysis 2009;113:5314-22.
98. Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008;143:321-35.
99. Cohn DM, Vansenne F, Kaptein AA, De Borgie CA, Middeldorp S. The psychological impact of testing for thrombophilia: a systematic review. J Thromb Haemost 2008;6:1099-104. (Pubitemid 351859118)
100. Nicolaides AN, Allegra C, Bergan JJ, Bradbury A, Cairols M, Carpentier P et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Int Angiol 2008;27:1-59.
101. Padberg FT, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial. J Vasc Surg 2004;39:79-87. (Pubitemid 38056156)
102. Partsch H, Flour M, Coleridge-Smith P. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Under the auspices of the IUP. Int Angiol 2008;27:193-219.
103. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Antithrombotic and thrombolytic therapy: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines. 8th ed. Chest 2008;133:110-2.
104. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007;146:211-22. (Pubitemid 351650635)
105. Thomas M, Hunt B. Pharmacological methods of thromboprophylaxis. Phlebology 2006;21:11-8.
106. Tooher R, Middleton P, Pham C, Fitridge R, Rowe S, Babidge W et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241:397-415. (Pubitemid 40299716)
107. Erkens PM, Prins MH. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2010;8:CD001100.
108. Barrett YC, Wang Z, Frost C, Shenker A. Clinical laboratory measurement of direct factor Xa Inhibitors: anti-Xa assay is preferable to prothrombin time assay. Thromb Haemost 2010 [In press].
109. Greinacher A. Heparin-induced thrombocytopenia. J Thromb Haemost 2009;7:9-12.
110. Greinacher A, Althaus K, Krauel K, Selleng S. Heparin-induced thrombocytopenia. Hamostaseologie 2010;30:17-8, 20-8.
111. Bauman ME, Belletrutti MJ, Bajzar L, Black KL, Kuhle S, Bauman ML et al. Evaluation of enoxaparin dosing requirements in infants and children. better dosing to achieve therapeutic levels. Thromb Haemost 2009;101:86-92.
112. Ignjatovic V, Najid S, Newall F, Summerhayes R, Monagle P. Dosing and monitoring of enoxaparin (low molecular weight heparin) therapy in children. Br J Haematol 2010;149:734-8.
113. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008;133:887-968.
114. Payne JH. Aspects of anticoagulation in children. Br J Haematol 2010;150:259-77.
115. Gouin-Thibault I, Siguret V, Pautas E. A need for evidence-based clinical practice guidelines for the use of heparins in the elderly. Clin Interv Aging 2010;26:119-21.
116. Kanagasabapathy P, Chowdary P, Gatt A. Alternatives to warfarin-the next generation of anticoagulants. Cardiovasc Ther 2010 [In press].
117. Salazar C, Malaga G, Malasquez G. Direct thrombin inhibitors versus vitamin k antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Database Syst Rev 2010;14:CD005981.
118. Samama MM, Martinoli JL, LeFlem L, Guinet C, Plu-Bureau G, Depasse F et al. Assessment of laboratory assays to measure rivaroxaban-an oral, Direct Factor Xa Inhibitor. Thromb Haemost 2010;103:815-25.
119. Uprichard J, Manning RA, Laffan MA. Monitoring heparin anticoagulation in the acute phase response. Br J Haematol 2010;149:613-9.
120. Cosmi B, Palareti G. Update on the predictive value of D-Dimer in patients with idiopathic venous thromboembolism. Thromb Res 2010;125:62-5.
121. East AT, Wakefield TW. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT. Semin Vasc Surg 2010;23:182-91.
122. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med 2010;363:1222-32.
123. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002;137:955-60.
124. Neglén P, Raju S. Balloon dilation and stenting of chronic iliac vein obstruction: technical aspects and early clinical outcome. J Endovasc Ther 2000;7:79-91. (Pubitemid 30614695)
125. Raju S, McAllister S, Neglén P. Recanalization of totally occluded iliac and adjacent venous segments. J Vasc Surg 2002;36:903-11. (Pubitemid 35316059)
126. Raju S, Owen S, Neglén P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg 2002;35:8-15.
127. Barwell JR, Davies CE, Deacon J, Harvey K, Minor J, Sassano A et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR Study): randomised controlled trial. Lancet 2004;363:1854-9. (Pubitemid 38748640)
128. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2001 ;doi: 10.1002/14651858.CD000265.pub2.
129. Nelson EA, Bell-Syer SE, Cullum NA. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev 2000;1:CD002303.
130. Nelson EA, Iglesias CP, Cullum N, Torgerson DJ. Randomized clinical trial of four-layer and short-stretch compression bandages for venous leg ulcers (VenUS I). Br J Surg 2004;91:1292-9. (Pubitemid 39331452)
131. O'Donnell TF. Venous ulcers: what really works and what does not, based on level I evidence. Vascular 2005;13:513-6.
132. Jull AB, Waters J, Arroll B. Pentoxifylline for treating venous leg ulcers. Cochrane Database Syst Rev 2002;18:CD001733.
133. Cabrera J, Redondo P, Becerra A, Garrido C, Cabrera J, Garcia-Olmedo MA et al. Ultrasound-guided injection of polidocanol microforamin the management of venous leg ulcers. Arch Dermatol 2004;140:667-73. (Pubitemid 38747281)
134. Partsch H, Clark M, Mosti G, Steinlechner E, Schuren J, Abel M et al. Classification of compression bandages: practical aspects. Dermatol Surg 2008;34:600-9. (Pubitemid 351569478)
135. Rabe E, Partsch H, Jünger M, Abel M, Achhammer I, Becker F et al. Guidelines for clinical studies with compression devices in patients with venous disorders of the lower limb. Eur J Vasc Endovasc Surg 2008;35:494-500. (Pubitemid 351296156)
136. Parsi K. Catheter-directed sclerotherapy. Phlebology 2009;24:98-107.
137. Parsi K, Exner T, Connor DE, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg 2007;34:731-40.
138. Parsi K, Exner T, Low J, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on antithrombotic mechanisms. Eur J Vasc Endovasc Surg 2008;38:220-8.
139. Parsi K, Exner T, Low J, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on clot formation and fibrinolysis. Eur J Vasc Endovasc Surg 2010;doi: 101016/jejvs201010004.
140. Parsi K, Exner T, Ma DDF, Joseph JE. In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors. Thromb Res 2010;126:328-36.
141. Parsi K, Exner T, Connor DE, Herbert A, Ma DD, Joseph JE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg 2008;36:216-23.
142. Cavezzi A, Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 2009;24:247-51.
143. Coleridge-Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-83.
144. Coleridge-Smith P. Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology 2009;24:260-9.
145. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5. (Pubitemid 38009913)
146. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-6.
147. Stücker M, Kobus S, Altmeyer P, Reich-Schupke S. Review of published information on foam sclerotherapy. Dermatol Surg 2010;36:983-92.
148. Gillet JL, Guedes JM, Guex JJ, Hamel-Desnos C, Schadeck M, Lauseker M et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:131-8.
149. Guex JJ. Complications and side-effects of foam sclerotherapy. Phlebology 2009;24:270-4.
150. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12 173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8. (Pubitemid 40990934)
151. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36:602-5.
152. Morrison N. Studies on safety of foam sclerotherapy. In: Bergan JJ, Cheng V, editors. Foam sclerotherapy: a textbook. London: Royal Society of Medicine Press; 2008. p. 182-92.
153. Parsi K. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Phlebology 2010 [In press].
154. Raymond-Martimbeau P. Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy. Phlebology 2009;24:114-9.
155. Fischer R, Chandler JG, De Maeseneer MG, Frings N, Lefebvre-Vilarbedo M, Earnshaw JJ et al. Collective review: the unresolved problem of recurrent saphenofemoral reflux. J Amer Coll Surg 2002;195:80-94.
156. Fischer R, Linde N, Duff C, Jeanneret C, Chandler JG, Seeber P. Late recurrent saphenofemoral junction reflux after ligation and stripping of the greater saphenous vein. J Vasc Surg 2001;34:236-40.
157. Perrin MR, Guex JJ, Ruckley CV, DePalma RG, Royle JP, Eklof B. Recurrent varices after surgery (REVAS): a consensus document. Cardiovasc Surg 2000;8:233-45.
158. van Rij AM, Chai J, Hill GB, Christie RA. Incidence of deep vein thrombosis after varicose vein surgery. Br J Surg 2004;91:1582-5. (Pubitemid 39619921)
159. Maleti O. Venous valvular reconstruction in postthrombotic syndrome. A new technique. J Mal Vasc 2002;27:218-21. (Pubitemid 35283172)
160. Petrin M. Reconstructive surgery for deep venous reflux: a report on 144 cases. Cardiovasc Surg 2000;8:246-55.
161. Teebken OE, Puschman C, Aper T, Haverich A, Mertsching H. Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg 2003;25:305-12. (Pubitemid 36527627)
162. Comerota AJ, Kagan SA. Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis. Phlebology 2001;15:149-55.
163. Comerota AJ, Thromb RC, Mathias S, Haughton S, Mewissen M. Catheter-Directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000;32:130-7. (Pubitemid 30461161)
164. Eklöf B, Kasirajan K. Treating proximal deep vein thrombosis. Endovasc Today 2003;4:17-23.
165. Kakkos SK, Rivera MA, Matsagas MI, Lazarides MK, Robless P, Belcaro G. Validation of the new venous severity scoring system in varicose vein surgery. J Vasc Surg 2003;38:224-8. (Pubitemid 41123245)
166. Meissner MH, Natiello C, Nicholls SC. Performance characteristics of the venous clinical severity score. J Vasc Surg 2002;36:89-95.
167. Perrin M, Dedieu F, Jessent V, Blanc MP. Evaluation of the new severity scoring in chronic venous disease of the lower limbs: an observational survey conducted by French angiologists. Phlebologie 2003;56:127-36.